. Corrigendum to laryngeal cancer with lung metastases showing long-term complete response and delayed immune-related adverse event after nivolumab discontinuation. Ear Nose Throat J 2022 Jun 22:1455613221110704. doi: 10.1177/01455613221110704.
PMID: 35731856